T2 Biosystems, Inc. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 20 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-11-30: Reporting owner Gibbs Michael Terrence; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-11-30: Reporting owner McDonough John; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-11-30: Reporting owner Lowery Thomas J.; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-06-02: Reporting owner Elsbree David B; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-11-30 | Gibbs Michael Terrence Officer (General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,500 0 owned after | $0.00 | 2019-02-05 | |
| 2017-11-30 | McDonough John Director, Officer (President & CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −47,423 0 owned after | $0.00 | 2019-02-05 | |
| 2017-11-30 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $0.00 | 2019-02-05 | |
| 2017-06-02 | Elsbree David B Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +18,000 18,000 owned after | $0.00 | 2018-06-05 | |
| 2017-06-02 | CUMMING JOHN W Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +18,000 18,000 owned after | $0.00 | 2018-06-05 | |
| 2017-06-02 | Cima Michael J. Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +18,000 18,000 owned after | $0.00 | 2018-06-05 | |
| 2017-06-02 | Lapidus Stanley Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +18,000 18,000 owned after | $0.00 | 2018-06-05 | |
| 2017-06-02 | LIEBMAN SEYMOUR Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +18,000 18,000 owned after | $0.00 | 2018-06-05 | |
| 2017-06-02 | CUMMING JOHN W Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $0.00 | 2017-06-06 | |
| 2017-06-02 | Cima Michael J. Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $0.00 | 2017-06-06 | |
| 2017-06-02 | LIEBMAN SEYMOUR Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $0.00 | 2017-06-06 | |
| 2017-06-02 | Lapidus Stanley Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $0.00 | 2017-06-06 | |
| 2017-06-02 | Elsbree David B Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $0.00 | 2017-06-06 | |
| 2017-02-09 | Dhanda Rahul Officer (SVP of Corporate Development) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $0.00 | 2017-02-13 | |
| 2017-02-09 | Harding David Officer (Chief Commercial Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $0.00 | 2017-02-13 | |
| 2017-02-09 | Lowery Thomas J. Officer (Chief Scientific Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $0.00 | 2017-02-13 | |
| 2017-02-09 | McDonough John Director, Officer (President & CEO) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.00 | 2017-02-13 | |
| 2017-02-09 | Lynch Shawn Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $0.00 | 2017-02-13 | |
| 2017-02-09 | Gibbs Michael Terrence Officer (General Counsel) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $0.00 | 2017-02-13 | |
| 2017-02-09 | Spadoro Joanne Officer (Chief Operations Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $0.00 | 2017-02-13 |